Medios AG: Extension of Management Board contracts of Manfred Schneider (CEO) and Matthias Gärtner (CFO)

Corporate News
 

Medios AG: Extension of Management Board contracts of Manfred Schneider (CEO) and Matthias Gärtner (CFO)​

Berlin, 18 October 2018 - The Supervisory Board of Medios AG ('Medios'), one of the leading Specialty Pharma companies in Germany, and the Management Board members Manfred Schneider, Chief Executive Officer (CEO), as well as Matthias Gärtner, Chief Financial Officer (CFO), have agreed today to extend the Management Board contract of Mr. Schneider by two years until 31 December 2020 and the Management Board contract of Mr. Gärtner by two and a half years until 30 June 2021. Mr. Schneider and Mr. Gärtner have been Management Board members since October 2016 and November 2014, respectively. Their current contracts are running until 31 December 2018 in accordance with their respective terms.

Yann Samson, Chairman of the Supervisory Board of Medios AG: 'With the contract extensions, the Supervisory Board acknowledges the significant contributions of Manfred Schneider and Matthias Gärtner to the profitable growth of Medios AG. We are looking forward to continuing our successful collaboration with the entire Management Board.'

The Management Board is completed by Ms. Mi-Young Miehler who is in charge of the operating business of Medios AG as Chief Operating Officer (COO) since July 2017.

About Medios AG
Medios AG is one of the leading Specialty Pharma companies in Germany. As wholesaler for Specialty Pharma drugs and GMP-certified manufacturer of patient-specific medications, Medios covers substantial elements of the supply chain in this field and follows the highest international quality standards. Specialty Pharma drugs are, in particular, individualised infusions for patients with rare or chronic diseases like cancer, HIV and hepatitis. It is Medios' aim to provide integrated solutions along the value chain to partners and clients, thereby ensuring an optimal pharmaceutical care for patients.

Medios AG is Germany's first listed Specialty Pharma company. The share (WKN: A1MMCC, ISIN: DE000A1MMCC8) is listed in the Regulated Market of the Frankfurt Stock Exchange (General Standard) and Hamburg-Hannover Stock Exchange.

Contact
Kirchhoff Consult AG
Nikolaus Hammerschmidt
Borselstraße 20
22765 Hamburg
Germany
Telephone: +49 40 60918618
Fax: +49 40 60918660
E-mail: nikolaus.hammerschmidt@kirchhoff.de
www.kirchhoff.de

Disclaimer
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.